Barcelona Institute for Global Health, Barcelona, Spain.
CIBER Epidemiologia y Salud Pública, Madrid, Spain.
Environ Health Perspect. 2023 Apr;131(4):47001. doi: 10.1289/EHP11989. Epub 2023 Apr 5.
Ambient air pollution has been associated with COVID-19 disease severity and antibody response induced by infection.
We examined the association between long-term exposure to air pollution and vaccine-induced antibody response.
This study was nested in an ongoing population-based cohort, COVICAT, the GCAT-Genomes for Life cohort, in Catalonia, Spain, with multiple follow-ups. We drew blood samples in 2021 from 1,090 participants of 2,404 who provided samples in 2020, and we included 927 participants in this analysis. We measured immunoglobulin M (IgM), IgG, and IgA antibodies against five viral-target antigens, including receptor-binding domain (RBD), spike-protein (S), and segment spike-protein (S2) triggered by vaccines available in Spain. We estimated prepandemic (2018-2019) exposure to fine particulate matter [PM in aerodynamic diameter ()], nitrogen dioxide (), black carbon (BC), and ozone () using Effects of Low-Level Air Pollution: A Study in Europe (ELAPSE) models. We adjusted estimates for individual- and area-level covariates, time since vaccination, and vaccine doses and type and stratified by infection status. We used generalized additive models to explore the relationship between air pollution and antibodies according to days since vaccination.
Among vaccinated persons not infected by SARS-CoV-2 (), higher prepandemic air pollution levels were associated with a lower vaccine antibody response for IgM (1 month post vaccination) and IgG. Percentage change in geometric mean IgG levels per interquartile range of () were (95% CI: , 0.4) for RBD, (, ) for S, and (, ) for S2. We observed a similar pattern for and BC and an inverse pattern for . Differences in IgG levels by air pollution levels persisted with time since vaccination. We did not observe an association of air pollution with vaccine antibody response among participants with prior infection ().
Exposure to air pollution was associated with lower COVID-19 vaccine antibody response. The implications of this association on the risk of breakthrough infections require further investigation. https://doi.org/10.1289/EHP11989.
环境空气污染与 COVID-19 疾病严重程度和感染引起的抗体反应有关。
我们研究了长期暴露于空气污染与疫苗诱导的抗体反应之间的关系。
本研究嵌套于西班牙加泰罗尼亚正在进行的基于人群的队列 COVICAT 中,GCAT-Genomes for Life 队列,有多次随访。我们从 2020 年提供样本的 2404 名参与者中抽取了 1090 名参与者的血液样本,并对 927 名参与者进行了分析。我们测量了针对五种病毒靶向抗原的免疫球蛋白 M(IgM)、IgG 和 IgA 抗体,包括疫苗触发的受体结合域(RBD)、刺突蛋白(S)和分段刺突蛋白(S2)。我们使用欧洲低水平空气污染影响研究(ELAPSE)模型估计了流行前(2018-2019 年)细颗粒物( )、二氧化氮()、黑碳(BC)和臭氧()的暴露水平。我们根据个人和地区水平的协变量、接种疫苗后的时间、疫苗剂量和类型以及感染状态调整了估计值。我们使用广义加性模型根据接种疫苗后的天数来探索空气污染与抗体之间的关系。
在未感染 SARS-CoV-2 的接种者中(),较高的流行前空气污染水平与 IgM(接种后 1 个月)和 IgG 的疫苗抗体反应较低相关。每个四分位距()的 IgG 水平几何均数变化百分比分别为 RBD 的 (95%CI: ,0.4)、S 的 ( , )和 S2 的 ( , )。我们观察到 和 BC 的类似模式,以及 的相反模式。随着接种疫苗后时间的推移,空气污染水平与 IgG 水平的差异仍然存在。我们没有观察到在有既往感染的参与者中,空气污染与疫苗抗体反应之间存在关联()。
暴露于空气污染与 COVID-19 疫苗抗体反应较低有关。这种关联对突破性感染风险的影响需要进一步调查。